Terms: = Leukemia AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Diagnosis
82 results:
1. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
[TBL] [Abstract] [Full Text] [Related]
2. [Suspicion of constitutional abnormality at diagnosis of childhood leukemia: Update of the leukemia committee of the French Society of Childhood Cancers].
Strullu M; Cousin E; de Montgolfier S; Fenwarth L; Gachard N; Arnoux I; Duployez N; Girard S; Guilmatre A; Lafage M; Loosveld M; Petit A; Perrin L; Vial Y; Saultier P
Bull Cancer; 2024 Mar; 111(3):291-309. PubMed ID: 38267311
[TBL] [Abstract] [Full Text] [Related]
3. Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.
Kemps PG; Kester L; Scheijde-Vermeulen MA; van Noesel CJM; Verdijk RM; Diepstra A; van Marion AMW; Dors N; van den Bos C; Bruggink AH; Hogendoorn PCW; van Halteren AGS
Histopathology; 2024 Apr; 84(5):837-846. PubMed ID: 38213281
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic leukemia in an Academic Clinical Laboratory.
Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
[TBL] [Abstract] [Full Text] [Related]
5. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
6. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
[TBL] [Abstract] [Full Text] [Related]
7. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
El Hussein S; Medeiros LJ; Lyapichev KA; Fang H; Jelloul FZ; Fiskus W; Chen J; Wei P; Schlette E; Xu J; Li S; Kanagal-Shamanna R; Yang H; Tang Z; Thakral B; Loghavi S; Jain N; Thompson PA; Ferrajoli A; Wierda WG; Jabbour E; Patel KP; Dabaja BS; Bhalla KN; Khoury JD
Pathology; 2023 Jun; 55(4):514-524. PubMed ID: 36933995
[TBL] [Abstract] [Full Text] [Related]
8. Secondary involvement of gallbladder by acute lymphoblastic leukemia presenting clinically as cholecystitis in a young patient: a case report.
Rahim S; Ahmad Z; Chundriger Q; Ahmed A; Ali N; Abdul-Ghafar J
World J Surg Oncol; 2023 Feb; 21(1):63. PubMed ID: 36843105
[TBL] [Abstract] [Full Text] [Related]
9. Autoantibodies to pax5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans.
Qiu C; Ma Y; Wang B; Zhang X; Wang X; Zhang JY
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835134
[TBL] [Abstract] [Full Text] [Related]
10. [pax5-positive plasma cell leukemia presenting as lymphocytosis].
Tateno S; Hirao M; Kikuchi T; Tsukada Y; Kunieda H; Osada M; Yamazaki K; Denda R; Hirose S; Matsushita M; Ichikawa D; Hattori Y
Rinsho Ketsueki; 2022; 63(10):1415-1420. PubMed ID: 36351649
[TBL] [Abstract] [Full Text] [Related]
11. pax5 P80R-mutated B-cell acute lymphoblastic leukemia with transformation to histiocytic sarcoma: clonal evolution assessment using NGS-based immunoglobulin clonality and mutation analysis.
Kroeze LI; Scheijen B; Hebeda KM; Rijntjes J; Luijks JACW; Evers D; Hobo W; Groenen PJTA; van den Brand M
Virchows Arch; 2023 Jul; 483(1):105-110. PubMed ID: 36241730
[TBL] [Abstract] [Full Text] [Related]
12. Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic leukemia.
Graiqevci-Uka V; Behluli E; Spahiu L; Liehr T; Temaj G
Curr Pediatr Rev; 2023; 19(2):150-156. PubMed ID: 36056858
[TBL] [Abstract] [Full Text] [Related]
13. CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: a histopathological study of 118 cases.
Maeshima AM; Taniguchi H; Hattori D; Sasaki H; Hori Y; Makita S; Iwaki N; Fukuhara S; Munakata W; Suzuki T; Izutsu K
Hum Pathol; 2022 Jun; 124():14-23. PubMed ID: 35307403
[TBL] [Abstract] [Full Text] [Related]
14. Philadelphia-like acute lymphoblastic leukemia: Characterization in a pediatric cohort in a referral center in Colombia.
Linares Ballesteros A; Yunis LK; García J; Aponte N; Flechas J; Martinez C; Uribe G; Quintero E; Díaz A; Pardo C; Sarmiento IC; Contreras A; Yunis JJ
Cancer Rep (Hoboken); 2022 May; 5(5):e1587. PubMed ID: 34787376
[TBL] [Abstract] [Full Text] [Related]
15. Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.
Tsuyuki Y; Kohno K; Inagaki Y; Sakai Y; Kosugi H; Takahashi E; Suzuki Y; Shimada S; Kato S; Takahara T; Satou A; Shimoyama Y; Nakamura S; Asano N; Sakakibara A
J Clin Exp Hematop; 2021; 61(3):173-179. PubMed ID: 34511545
[TBL] [Abstract] [Full Text] [Related]
16. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
[TBL] [Abstract] [Full Text] [Related]
17. [Effect of CDK1 Interferes with the Regulation of PLK1, Aurora B and TRF1 on the Proliferation of leukemia Cells].
Li HM; Chang XX; Huang LQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1156-1162. PubMed ID: 34362496
[TBL] [Abstract] [Full Text] [Related]
18. Identification of novel, clonally stable, somatic mutations targeting transcription factors pax5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).
Burlet B; Ramla S; Fournier C; Abrey-Recalde MJ; Sauter C; Chrétien ML; Rossi C; Duffourd Y; Ragot S; Buriller C; Tournier B; Chapusot C; Nadal N; Racine J; Guy J; Bailly F; Martin L; Casasnovas O; Bastie JN; Caillot D; Albuisson J; Broccardo C; Thieblemont C; Delva L; Maynadié M; Aucagne R; Callanan MB
Cold Spring Harb Mol Case Stud; 2021 Feb; 7(1):. PubMed ID: 33608382
[TBL] [Abstract] [Full Text] [Related]
19. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
[TBL] [Abstract] [Full Text] [Related]
20. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic leukemia with Prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract] [Full Text] [Related]
[Next]
